Across Europe, the tectonic plates of merger control are
shifting. The familiar comfort of turnover thresholds, the
traditional barometer for measuring and screening transactions, no
longer guarantees safe passage. A new era of scrutiny has begun,
marked by the expanding reach of EU Merger Regulation (EUMR)
Article 22 referrals, the rise of discretionary "call-in"
powers, and a jurisprudence that appears ever more willing to
stretch jurisdictional limits. Deals once thought too small, too
local, or too marginal are now being caught in the net of
competition law. The consequences extend well beyond the
headline-grabbing worlds of Big Tech and pharmaceuticals; even
modest cross-border acquisitions risk finding themselves under the
European Commission's gaze.By discretionary
"call-in", we mean the authority's power to require
notification of a transaction that (i) falls below the ordinary
thresholds, or (ii) meets an alternative statutory threshold that,
while not